Jailani, Ajmir N.
HRN: 21-29-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/01/2022
05/14/2022
IVT
560 Mg
Q6
PCAP C With Massive Pleural Effusion, To Complete Antibiotics For 10-14 Days
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes